Literature DB >> 11457532

Recombinant BCG vaccines.

N Ohara1, T Yamada.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11457532     DOI： 10.1016/s0264-410x(01)00155-4

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  18 in total

Review 1.  Bacterial infectious disease control by vaccine development.

Authors:  Roy Curtiss
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

2.  Evaluation of a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL/6 mice.

Authors:  Jiu ling Wang; Ya qing Qie; Bing dong Zhu; Hong mei Zhang; Ying Xu; Qing zhong Wang; Jia zhen Chen; Wei Liu; Hong hai Wang
Journal:  Med Microbiol Immunol       Date:  2008-05-20       Impact factor: 3.402

3.  Immune response induced by recombinant Mycobacterium bovis BCG producing the cholera toxin B subunit.

Authors:  Franck Biet; Laurent Kremer; Isabelle Wolowczuk; Myriam Delacre; Camille Locht
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

4.  Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice.

Authors:  Jun Fujii; Mariko Naito; Takashi Yutsudo; Sohkichi Matsumoto; Daniel P Heatherly; Takeshi Yamada; Hideyuki Kobayashi; Shin-Ichi Yoshida; Tom Obrig
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

5.  Molecular characterization of heterologous HIV-1gp120 gene expression disruption in mycobacterium bovis BCG host strain: a critical issue for engineering mycobacterial based-vaccine vectors.

Authors:  Joan Joseph; Raquel Fernández-Lloris; Elías Pezzat; Narcís Saubi; Pere-Joan Cardona; Beatriz Mothe; Josep Maria Gatell
Journal:  J Biomed Biotechnol       Date:  2010-06-27

6.  Development of Th1 imprints to rBCG expressing a foreign protein: implications for vaccination against HIV-1 and diverse influenza strains.

Authors:  Carl Power; Travis W Marfleet; Louis Qualtiere; Wei Xiao; Peter Bretscher
Journal:  J Biomed Biotechnol       Date:  2010-06-07

7.  Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination.

Authors:  B M Buddle; D N Wedlock; N A Parlane; L A L Corner; G W De Lisle; M A Skinner
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.

Authors:  James A Triccas; Elena Shklovskaya; Joanne Spratt; Anthony A Ryan; Umaimainthan Palendira; Barbara Fazekas de St Groth; Warwick J Britton
Journal:  Infect Immun       Date:  2007-08-27       Impact factor: 3.441

9.  Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.

Authors:  Paula B Varaldo; Luciana C C Leite; Waldely O Dias; Eliane N Miyaji; Fabio I G Torres; Vera C Gebara; Geraldo R G Armôa; Adriano S Campos; Denise C S Matos; Nathalie Winter; Brigitte Gicquel; Mônica M Vilar; Johnjoe McFadden; Marilia S Almeida; Miriam Tendler; Douglas McIntosh
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 10.  The current status, challenges, and future developments of new tuberculosis vaccines.

Authors:  Wenping Gong; Yan Liang; Xueqiong Wu
Journal:  Hum Vaccin Immunother       Date:  2018-05-14       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.